Ciprofloxacin
Is It Right for You?
A complete guide to Ciprofloxacin — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Ciprofloxacin?
Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic used to treat a wide range of serious bacterial infections. It belongs to the second generation of quinolone antibiotics and is particularly valued for its activity against Gram-negative organisms, its excellent tissue penetration, and its availability in both oral and intravenous forms – making it one of the few antibiotics that can be used interchangeably between community and hospital settings.
First approved in the 1980s, ciprofloxacin quickly became one of the most widely prescribed antibiotics in the world due to its broad spectrum of activity, high oral bioavailability, and once or twice daily dosing convenience. However, in recent years its use has been increasingly restricted in UK primary care guidelines due to concerns about serious side effects – particularly tendon damage, peripheral neuropathy, and psychiatric effects – and its association with Clostridioides difficile infection and the development of antibiotic resistance. Current guidance from the Medicines and Healthcare products Regulatory Agency (MHRA) recommends that ciprofloxacin should be reserved for conditions where other antibiotics are not suitable.
Ciprofloxacin is available in tablet, oral suspension, and intravenous infusion forms, as well as topical preparations for ear and eye infections. It is suitable for adults and, in specific circumstances, children. It is available generically and under brand names including Ciproxin.
Ciprofloxacin is a prescription-only medication in the UK. A licensed clinician must assess your symptoms and medical history before it can be prescribed – which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Ciprofloxacin Used For?
Ciprofloxacin is prescribed for a range of bacterial infections, typically where first-line antibiotics are unsuitable or have failed:
complicated UTIs and pyelonephritis (kidney infections) caused by susceptible organisms; used when first-line agents such as trimethoprim or nitrofurantoin are inappropriate.
severe community-acquired pneumonia, hospital-acquired pneumonia, and acute exacerbations of COPD caused by susceptible Gram-negative organisms.
bacterial gastroenteritis, traveller's diarrhoea caused by Campylobacter, Salmonella, Shigella, or E. coli; typhoid fever.
complicated skin infections where Gram-negative organisms are suspected or confirmed, including infected diabetic foot ulcers.
gonorrhoea (though resistance is now widespread and ciprofloxacin is no longer first-line; sensitivity testing is required
bacterial prostatitis, one of the few conditions for which ciprofloxacin remains a preferred antibiotic due to its excellent penetration into prostate tissue.
single-dose ciprofloxacin is used as post-exposure prophylaxis for close contacts of meningococcal disease.
ciprofloxacin ear drops are used for acute otitis externa and chronic suppurative otitis media.
osteomyelitis and septic arthritis caused by susceptible organisms, particularly in combination regimens.
post-exposure prophylaxis and treatment of cutaneous, inhalational, and gastrointestinal anthrax caused by Bacillus anthracis.
ciprofloxacin eye drops are used for bacterial conjunctivitis and corneal ulcers.
Due to concerns about serious side effects and antibiotic resistance, UK prescribing guidelines recommend that ciprofloxacin should not be used as a first-line antibiotic for most common infections where alternative agents are available. It is most appropriately reserved for complicated infections, infections caused by resistant organisms, or situations where no suitable alternative exists. A clinician will assess whether ciprofloxacin is the most appropriate choice for your specific infection.
How Does Ciprofloxacin Work?
Ciprofloxacin belongs to the fluoroquinolone class of antibiotics and exerts its bactericidal effects by targeting two essential bacterial enzymes involved in DNA replication and repair: DNA gyrase (topoisomerase II) and topoisomerase IV.
These enzymes are responsible for controlling the supercoiling and unwinding of bacterial DNA during replication and transcription – processes that are essential for bacteria to copy their genetic material and produce the proteins needed for growth and survival. Ciprofloxacin forms stable complexes with these enzymes and the bacterial DNA strand, effectively trapping the enzymes in a state that causes irreparable double-strand breaks in the DNA. This prevents the bacteria from replicating their DNA, halts protein synthesis, and ultimately causes bacterial cell death.
Because ciprofloxacin directly destroys bacterial DNA, it is bactericidal – it kills bacteria outright rather than simply inhibiting their growth. Its mechanism is entirely different from beta-lactam antibiotics (which target cell walls) and macrolides or tetracyclines (which target ribosomes), which is why it is effective against many organisms that are resistant to these other antibiotic classes.
Ciprofloxacin has excellent oral bioavailability (approximately 70–80%), meaning that oral doses achieve blood levels close to those achieved by intravenous administration. It also achieves very high concentrations in many tissues – including the prostate, bone, lung, and kidneys – making it effective for infections in these sites. Its activity is predominantly against Gram-negative bacteria, though it also covers some Gram-positive and atypical organisms.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Ciprofloxacin tablets can be taken with or without food. Food does not significantly affect absorption, though taking with food may reduce nausea. Avoid taking with dairy products or calcium-fortified foods immediately before or after the dose, as calcium can reduce absorption.
Avoid taking ciprofloxacin within 2 hours before or 6 hours after antacids containing aluminium, magnesium, or calcium; iron supplements; zinc supplements; or sucralfate. These products bind to ciprofloxacin in the gut, significantly reducing its absorption and effectiveness.
Maintain adequate hydration throughout treatment. Ciprofloxacin can rarely cause crystalluria (crystals in the urine), and drinking sufficient water reduces this risk and supports kidney function.
Avoid excessive caffeine during ciprofloxacin treatment, as ciprofloxacin inhibits caffeine metabolism, which can lead to caffeine accumulation and cause agitation, palpitations, and insomnia.
Avoid prolonged sun exposure and sunbeds during treatment. Ciprofloxacin can cause photosensitivity, increasing the risk of sunburn. Use high-SPF sunscreen and protective clothing when outdoors.
Stop ciprofloxacin immediately and rest the affected area if you experience any pain, swelling, or inflammation in a tendon, particularly the Achilles tendon. Contact your clinician promptly. Do not wait to see if it resolves.
Always complete the full prescribed course even if symptoms improve early, to ensure the infection is fully eradicated and reduce the risk of resistance.
Side Effects of Ciprofloxacin
Ciprofloxacin has a well-documented safety profile that includes some serious side effects that are not commonly associated with other antibiotic classes. Patients should be made aware of these before starting treatment.
- Nausea
- Diarrhoea
- Vomiting
- Abdominal discomfort
- Headache
- Dizziness
- Rash
- Elevated liver enzymes (usually asymptomatic)
- Tendinopathy and tendon rupture – pain, swelling, or rupture of tendons, most commonly the Achilles tendon; can occur during treatment or up to several months after; risk is substantially higher in patients over 60, those on corticosteroids, and those with kidney disease
- Peripheral neuropathy – numbness, tingling, burning, or weakness in the limbs; can be irreversible; stop ciprofloxacin immediately if these symptoms develop
- Central nervous system effects – seizures, confusion, hallucinations, agitation, anxiety, depression, insomnia, and psychosis; can occur even on the first dose
- Cardiac arrhythmias (QT prolongation) – potentially fatal heart rhythm disturbances, particularly in patients with pre-existing cardiac conditions or those taking other QT-prolonging drugs
- Aortic aneurysm and dissection – rare but serious; ciprofloxacin has been associated with weakening of the aortic wall; avoid in patients with known aortic aneurysm or risk factors
- C. difficile-associated diarrhoea – persistent watery or bloody diarrhoea, abdominal cramping, fever
- Severe allergic reaction (anaphylaxis) – hives, facial or throat swelling, difficulty breathing, collapse
- Hepatotoxicity – jaundice, dark urine, pale stools, severe fatigue; rare
- Blood sugar disturbances – both hypoglycaemia and hyperglycaemia have been reported, particularly in diabetic patients on antidiabetic medications
- Myasthenia gravis exacerbation – ciprofloxacin can worsen neuromuscular blockade in patients with myasthenia gravis
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has issued guidance highlighting that fluoroquinolone antibiotics including ciprofloxacin are associated with rare but disabling and potentially irreversible side effects affecting tendons, muscles, joints, nerves, and the central nervous system. These reactions have been reported to occur together as a syndrome in some patients. Ciprofloxacin should be discontinued at the first sign of any serious adverse reaction and should not be prescribed for mild or self-limiting infections where other options are available.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting ciprofloxacin.
Combining ciprofloxacin with other QT-prolonging medications significantly increases the risk of serious, potentially fatal cardiac arrhythmias. This combination should generally be avoided or used only under close cardiac monitoring.
Ciprofloxacin dramatically increases plasma levels of tizanidine (a muscle relaxant) by inhibiting its metabolism, causing severe hypotension and sedation. This combination is contraindicated.
Ciprofloxacin significantly inhibits the metabolism of theophylline, causing potentially toxic plasma levels. Theophylline levels must be monitored closely and the dose reduced when ciprofloxacin is prescribed concurrently.
These products chelate ciprofloxacin in the gut, dramatically reducing its absorption and potentially rendering it ineffective. Take ciprofloxacin at least 2 hours before or 6 hours after these products.
Ciprofloxacin enhances the anticoagulant effect of warfarin, significantly increasing bleeding risk. INR must be monitored closely during and after treatment in patients taking warfarin.
Ciprofloxacin can cause both hypoglycaemia and hyperglycaemia in patients taking antidiabetic medications. Blood glucose should be monitored more closely during treatment.
Concurrent use of ciprofloxacin and corticosteroids substantially increases the risk of tendon rupture. This combination should be avoided where possible, particularly in elderly patients.
Concurrent use of NSAIDs with ciprofloxacin may increase the risk of CNS stimulation and seizures. Avoid this combination where possible, particularly in patients with a history of epilepsy.
Ciprofloxacin may reduce the renal excretion of methotrexate, raising blood levels to potentially toxic concentrations. Close monitoring is required if both drugs must be used concurrently.
Ciprofloxacin inhibits caffeine metabolism, leading to accumulation of caffeine. This can cause agitation, palpitations, insomnia, and tremor. Reduce caffeine intake during ciprofloxacin treatment.
Important Warnings
Ciprofloxacin and other fluoroquinolones are associated with tendinitis (tendon inflammation) and tendon rupture, most commonly affecting the Achilles tendon. Rupture can occur during treatment or up to several months after stopping. Risk is substantially higher in patients over 60, those receiving concurrent corticosteroid treatment, patients with kidney disease, and those who have undergone organ transplantation. Stop ciprofloxacin immediately and rest the affected limb if tendon pain, swelling, or inflammation develops. Seek prompt medical assessment.
.
Ciprofloxacin can cause peripheral neuropathy – damage to the nerves of the limbs – presenting as burning, tingling, numbness, or weakness. This can develop rapidly after starting treatment and may be irreversible if ciprofloxacin is not stopped promptly. Contact your clinician immediately if any of these symptoms develop during or after treatment.
Serious psychiatric and neurological effects including seizures, confusion, hallucinations, depression, anxiety, and psychosis have been reported with ciprofloxacin, sometimes on the first dose. Patients with a history of epilepsy, CNS conditions, or psychiatric disorders are at higher risk. Seek immediate medical attention if these symptoms develop.
Ciprofloxacin has been associated with an increased risk of aortic aneurysm and aortic dissection – rare but potentially fatal conditions caused by weakening of the aortic wall. Ciprofloxacin should be used with extreme caution or avoided in patients with known aortic aneurysm, risk factors for aortic disease (hypertension, atherosclerosis, Marfan syndrome), or a family history of aortic disease. Seek emergency medical attention if you develop sudden severe chest, back, or abdominal pain during ciprofloxacin treatment
Ciprofloxacin prolongs the cardiac QT interval and can trigger serious arrhythmias. Risk is highest in patients with pre-existing cardiac conditions, electrolyte abnormalities, or those taking other QT-prolonging medications. Always disclose your full cardiac and medication history before being prescribed ciprofloxacin.
Ciprofloxacin is one of the antibiotics most commonly associated with Clostridioides difficile infection. If you develop persistent, watery, or bloody diarrhoea during or after treatment, contact a clinician promptly and do not self-treat with anti-diarrhoeal medications.
Ciprofloxacin is generally not recommended during pregnancy as it may affect developing cartilage and joints in the foetus, based on animal studies. Alternative antibiotics are almost always available. Ciprofloxacin passes into breast milk and is not recommended during breastfeeding. Always inform your clinician if you are pregnant or breastfeeding before starting any antibiotic.
Ciprofloxacin is generally avoided in children and adolescents due to concerns about potential effects on developing cartilage and joints. It is used in paediatric patients only for specific, serious infections where no alternative exists, and under specialist supervision.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Ciprofloxacin FAQs
Yes. A licensed clinician can assess your symptoms and medical history via a telehealth consultation and prescribe ciprofloxacin if it is clinically appropriate. Given current UK prescribing guidance, ciprofloxacin is typically reserved for infections where first-line antibiotics are unsuitable. Prescriptions are typically sent to your preferred pharmacy the same day, often within minutes of your consultation.
Ciprofloxacin is rapidly absorbed and begins working within a few hours of the first dose. Most patients notice a meaningful improvement in symptoms within 48 to 72 hours. For kidney infections and prostatitis, improvement may take several days longer due to the depth of tissue involvement.
UK prescribing guidelines have increasingly restricted ciprofloxacin use due to two main concerns. First, serious and potentially irreversible side effects – including tendon rupture, peripheral neuropathy, and psychiatric effects – that are unique to fluoroquinolones and are considered disproportionately severe for treating minor or moderate infections. Second, the high rate of antibiotic resistance associated with fluoroquinolone overuse, and the association with C. difficile infections. Ciprofloxacin remains an important antibiotic for specific serious infections but should no longer be used routinely when safer alternatives exist.
Stop taking ciprofloxacin immediately and rest the affected area – do not exercise or put weight on the affected tendon. Contact your clinician promptly for assessment. Continuing to use a tendon that has been affected by fluoroquinolone-related tendinopathy significantly increases the risk of complete rupture, which may require surgical repair.
Yes, ciprofloxacin is effective for urinary tract infections including kidney infections (pyelonephritis). However, for uncomplicated lower UTIs, first-line antibiotics such as nitrofurantoin or trimethoprim are preferred in UK guidelines. Ciprofloxacin is typically reserved for complicated UTIs, kidney infections, or cases where first-line agents are contraindicated or have failed.
Not at the same time. Antacids containing aluminium, magnesium, or calcium significantly reduce the absorption of ciprofloxacin, potentially making it ineffective. If you need to take antacids, space them at least 2 hours before or 6 hours after your ciprofloxacin dose.
Ciprofloxacin inhibits the liver enzyme responsible for breaking down caffeine, causing it to accumulate in the body. This can lead to excessive caffeine effects including agitation, restlessness, palpitations, insomnia, and tremor. Reducing or avoiding caffeine – including tea, coffee, energy drinks, and cola – during treatment is advisable.
Ciprofloxacin can be used in elderly patients but requires particular caution. Older patients are at significantly higher risk of tendon rupture and are more susceptible to CNS side effects and QT prolongation. The lowest effective dose should be used, concurrent corticosteroids should be avoided where possible, and close monitoring is essential.
There is no known dangerous direct interaction between alcohol and ciprofloxacin. However, alcohol can suppress the immune system, worsen dehydration, and interact with the side effect profile of ciprofloxacin – particularly dizziness and CNS effects. It is advisable to avoid or minimise alcohol during treatment.
Take the missed dose as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue as normal. Do not take a double dose. Space the remaining doses as evenly as possible throughout the day.